Navigation Links
Moravia Provides Guidance to Life Sciences Sector as Croatia Nears EU Accession and European Medicines Agency Deadlines Loom
Date:4/10/2013

NEWBURY PARK, Calif., April 10, 2013 /PRNewswire/ -- As Croatia prepares to join the European Union (EU) on July 1, global and regional life sciences companies are facing regulatory and compliance deadlines in accordance with EU European Medicines Agency (EMA) standards.

(Logo: http://photos.prnewswire.com/prnh/20121012/DA92092LOGO)

The EMA legally requires that pharmaceutical companies using the EMA's centralized marketing authorization procedure make their product information available in any new EU member's official language as of the member's date of accession. This means companies must accurately localize and translate all product labels and documentation into Croatian before July 1, otherwise they cannot market those products in the EU.

Moravia, a leading globalization company that helped pioneer localization in Croatia, says time is running out before the EMA's pending April 30 deadline for companies to submit translated documents and labels for verification. Any information sent past that deadline might not be certified by the EMA before Croatia's accession date, causing delay and missed marketing opportunities.

"Due to the size of the language, there is a limited pool of Croatian translators that can provide accurate product information translations. Therefore, it's important that companies choose a quality partner to help them smoothly navigate the EMA process," said Renato Beninatto , Chief Marketing Officer at Moravia. "Time is of the essence for companies trying to meet the Croatia accession deadlines. But new translation technologies available through providers like Moravia can help ensure fast project turnaround and delay-free regulatory approval."

A translation leader in the life sciences industry, Moravia holds ISO 13485 and EN 15038 certifications that illustrate the company's commitment to the industry's global standards.

About Moravia

Moravia is a leading globalization solution provider, enabling companies in the information technology, e-learning, and life sciences industries to enter global markets with high-quality multilingual products. Moravia's solutions include localization, product testing, internationalization, multilingual publishing, technical translation, content creation, machine translation, and workflow consulting. The company maintains global headquarters in the Czech Republic and North American headquarters in California, with local offices and production centers in Japan, China, Latin America, Ireland, USA and throughout Europe. www.moravia.com.

 


'/>"/>
SOURCE Moravia
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MediPendant™ to Return to Television on May 20th New Television Campaign - Company Provides MediPendant™ Update
2. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
3. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
4. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
5. Elevate Provides Remote Access to Personal Health Records Using MyMedicalRecords.com
6. Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona
7. NexGen Biomedical, Inc. Provides New Insights Into Jett Travoltas Seizure Related Death
8. Concord Medical Announces its Successful Closing of the Acquisition of 52% Ownership in Changan Hospital and Provides Guidance for Financial Results of the Second Quarter of 2012
9. TPI Provides Further Updates on its GMOL Flagship Product
10. BSGI Molecular Breast Imaging Provides Better Results than MRI for Cancer Patients with Dense Breasts
11. Publication of PrEP Trial Data Provides Clear Evidence that PrEP Works for Men and Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia ... the company,s second affiliate in Latin America . ... ... Farma Colombia ... ...
(Date:6/23/2016)... Tenn. , June 23, 2016 /PRNewswire/ ... automating, integrating and transforming the patient payment ... of several innovative new products and services ... of its revenue cycle offerings. These award-winning ... more efficient workflows, remain compliant in an ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):